Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002985 · ClinicalTrials.gov registry record · Phase 3
Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
A Phase 3 study of Sarcoma, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00002985: Completed Phase 3 study of Sarcoma, sponsored by Roswell Park Cancer Institute.
NCT00002985 is a Phase 3 study of Sarcoma that has completed, run by Roswell Park Cancer Institute. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002985, a Phase 3 study of Sarcoma, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether doxorubicin is more effective than daunorubicin for AIDS-related Kaposi's sarcoma. PURPOSE: Randomized double-blinded phase III trial to determine if doxorubicin is more effective than daunorubicin in treating patients who have AIDS-related Kaposi's sarcoma.
Conditions Studied
Interventions
- DRUG pegylated liposomal doxorubicin hydrochloride
- DRUG daunorubicin hydrochloride
Study Locations (1)
New York
- Roswell Park Cancer Institute - Buffalo
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-11 |
| Phase | Phase 3 |
What the finished NCT00002985 record still lists
NCT00002985 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Sarcoma appearing as the primary indexed condition, and to 2 interventions - of which pegylated liposomal doxorubicin hydrochloride is the first listed.
NCT00002985 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00002985 about?
NCT00002985 is a clinical study titled "Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether doxorubicin is more effective than daunorubicin for AIDS-related Kaposi's sarcoma. PURPOSE: Randomized double-blinded phase III trial to determine if d...
What is the current status of trial NCT00002985?
This trial is currently completed. It is a Phase 3 study. The study started on 1996-11.
What conditions does trial NCT00002985 study?
This clinical trial studies the following conditions: Sarcoma.
What interventions are being tested in trial NCT00002985?
The interventions under investigation include: pegylated liposomal doxorubicin hydrochloride (DRUG), daunorubicin hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002985?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002985 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
ACTIVE NOT RECRUITING · Phase 3
-
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
COMPLETED · Phase 3
-
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
COMPLETED · Phase 3
-
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families
COMPLETED · Phase 3
-
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
COMPLETED · Phase 3
-
Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia